One time weight-loss therapy? Gene therapy could revolutionize the GLP-1 industry, but challenges remain

One time weight-loss therapy? Gene therapy could revolutionize the GLP-1 industry, but challenges remain

Washington Post |
A cardiologist by training, [Harith] Rajagopalan believes there’s a better way to harness the benefits of GLP-1 drugs: a gene ...
Next phase in the weight loss revolution

Next phase in the weight loss revolution

Washington Post |
For all the societal changes ushered in by GLP-1 drugs, their lofty price tags limit who can afford them. Many patients stop ...
Rejecting consensus science and following RFK, Jr.’s playbook, Texas sues Tylenol, claiming it knew the painkiller causes autism

Rejecting consensus science and following RFK, Jr.’s playbook, Texas sues Tylenol, claiming it knew the painkiller causes autism

Washington Post |
Texas Attorney General Ken Paxton filed a lawsuit ... against Tylenol-maker Kenvue and its former parent company, Johnson & Johnson, ...
A new therapy has been developed that promoters claim can remove microplastics from the body. Is it safe? Does it work?

A new therapy has been developed that promoters claim can remove microplastics from the body. Is it safe? Does it work?

Washington Post |
There is mounting evidence that microplastics and “forever chemicals” are infiltrating human bodies and endangering people’s health. ... Interventions to ...
b dc f f f cc fd e fa

Ancient African shrub ibogaine causes psychedelic hallucinations — and can reduce anxiety, depression, and PTSD. Why is it restricted in the US?

Washington Post |
Stephen Jones suffers from a traumatic brain injury, but a psychedelic called ibogaine eased his suffering ...
Elon Musk’s Neuralink brain implant approved for human trials by the FDA

Elon Musk’s Neuralink brain implant approved for human trials by the FDA

Washington Post |
Elon Musk's brain-implant company Neuralink said May 25 that it got approval from the U.S. Food and Drug Administration to ...